Title: Study of Incidence of Congenital Rubella and cytomegalo virus infections in Children’s, Attending in Tertiary care Hospital at New Delhi

Authors: Dr Ratnesh Kumar, Dr Sima Choudhary, Dr T.P.Yadav

 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.110

Abstract

Objective: The present study was undertaken to determine the role of Rubella and cytomegalo virus (CMV) infections of children and pregnant woman.

Materials and Methods: A total of 232 children were screened for suspected Rubella infection and 276 children were screened for CMV infection. A total of 34 asymptomatic pregnant women were screened for CMV and 112 Asymptomatic Pregnant women for Rubella infection. Pregnant woman with obstetric complications were screened for CMV (n=66) and Rubella (n=282). Blood samples from pregnant woman (Asymptomatic and also woman with obstetric problems) and children (suspected of intrauterine infections) were collected and send to laboratories for tests. The samples were tested for Rubella and CMV specific IgM antibodies by CMIA methods. 

Results: In children, overall positivity for Rubella and CMV specific IgM antibodies was 3.44% and 12.67% respectively. In asymptomatic Pregnant females Rubella positivity was 0.89%, while with obstetric complication it was 4.96%. IgM antibody positivity in cases of CMV was 8.82% in asymptomatic pregnant woman and 7.57% in woman with obstetric complications.

Conclusion: The study indicated that infection with CMV is more common than the rubella virus. The incidence of rubella infections were decreases in the past few years. Hence, screening for rubella infection may be reserved for women with obstetric complications only. The routine screening for CMV among all antenatal cases is a debatable issue.

Keywords: Cytomegalovirus, congenital infection, IgM antibodies, rubella.

References

  1. Onorato IM, Morens DM, Martone WJ, Stansfield SK. Epidemiology of CMV infections: Recommendations for prevention and control. Rev Infect Dis 1985;7:479-97.
  2. Gupta E, Dar L, Broor S. Seroprevalence of rubella in pregnant women in Delhi, India. Indian J Med Res 2006;123:833-5.
  3. Vijayalakshmi P, Anuradha R, Prakash K, Nrendran K, Ravindran M, Prajna L, et al. Rubella serosurveys at three Aravind eye hospitals in Tamil Nadu, India. Bull World Health Organ 2004;82:259-64.
  4. Gandhoke I, Aggarwal A, Lal S, Khare S. Seroprevalence and incidence of Rubella in and around Delhi (1988-2002). Indian J Med Microbiol2005;23:164-7.
  5. Chakravarti A, Jain M. Rubella prevalence and its transmission in children. Indian J Pathol Microbiol 2006;49:54-6.
  6. Fomda BA, Thokar MA, Farooq U, Sheikh A. Seroprevalence of rubella in pregnant women in Kashmir. Indian J Pathol Microbiol2004;47:435-7.
  7. Singla N, Jindal N, Aggarwal A. Primary rubella virus infection: Prevalence and relationship to pregnancy wastage. Indian J Pathol Microbiol 2003;46:688-9.
  8. Thapliyal N, Shukla PK, Kumar B, Upadhyay S, Jain G. TORCH infection in women with bad obstetric history: A pilot study in Kumaon region. Indian J Pathol Microbiol 2005;48:551-3.
  9. Chakravarty A, Kashyap B, Rathi K. The seroepidemiological study on cytomegalovirus in women of child-bearing age with special reference to pregnancy and maternal-fetal transmission. Indian J Pathol Microbiol 2005;48:518-21.
  10. Ray K, Mahajan M. Seroprevalence of cytomegalovirus antibodies in patients attending STD and antenatal clinics. J Commun Dis 1997;29:85-90.
  11. Kimberlin DW, Lin CY, Sandez P, et al. Ganciclovir (GCV) treatment of symptomatic congenital cytomegalovirus (CMV) infections: Result of a phase III randomised trial. In Program and abstracts of the fortieth interscience conference on antimicrobial agents and chemotherapy, Toronto, Canada, 2000. Abstract 1942.p 274. American Society for Microbiology, Washington DC, USA.

Corresponding Author

Dr Ratnesh Kumar

Specialist Medical Officer, P.H.C, Naubatpur, Patna. (MBBS, MD- Paediatrics)